Tetracycline-class Antibacterial class drugs
4 results
Nuzyra (omadacycline)
(omadacycline)Paratek Pharmaceuticals, Inc.
Usage: NUZYRA is indicated for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by specific susceptible bacteria. It should be used to treat infections proven or suspected to be due to these organisms to reduce drug resistance.
Tigecycline (tigecycline)
(TIGECYCLINE)Apotex Corp
Usage: Tigecycline is indicated for patients aged 18 and older to treat complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia caused by susceptible bacteria. It is not suitable for diabetic foot infections or hospital-acquired pneumonia due to efficacy concerns.
Tygacil (tigecycline)
(TIGECYCLINE)Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Usage: TYGACIL is indicated for treating complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia in patients aged 18 and older, caused by specific susceptible bacteria. It is not recommended for diabetic foot infections or hospital-acquired/ventilator-associated pneumonia due to efficacy and safety concerns.
Xerava (eravacycline)
(eravacycline)Tetraphase Pharmaceuticals, Inc.
Usage: XERAVA is indicated for treating complicated intra-abdominal infections (cIAI) in adults caused by specific susceptible bacteria. It should not be used for complicated urinary tract infections (cUTI) and is meant to combat drug resistance by targeting known or suspected susceptible bacteria.